Evidence map›Paper›PMID 23881647›Full record

ReviewCurrent osteoporosis reports2013

Vitamin D and skeletal growth and development.

Winston Koo, Nitin Walyat

Abstract readComparative StudyReview
PubMed Publisher
In one paragraph

Review in Current osteoporosis reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Winston KooDepartment of Pediatrics, Louisiana State University Health Sciences Center-Shreveport, 1501 King's Hwy, Shreveport, LA, 71103, USA, wkoo@lsuhsc.edu.
Nitin Walyat
Louisiana State University Health Sciences Center Shreveport · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D is critical to bone mineral metabolism and to the growth and development of the skeleton. Optimizing vitamin D status could be one of the cornerstones to optimize skeletal growth and achieving the maximum peak bone mass soon after the completion of adolescence. Maximizing peak bone mass is considered to be the key to primary prevention of osteoporosis. There is controversy, however, about what constitutes a healthy vitamin D status based on the most abundant circulating metabolite of vitamin D, namely 25 hydroxyvitamin D (25 OHD) in plasma or serum; and even the value of 25 OHD that should be used to define vitamin D deficiency. We reviewed the recent data on circulating 25 OHD concentrations and its relationship with skeletal growth in apparently healthy children and in those with nutritional vitamin D deficiency.

Indexed as

AdolescentBiomarkersBone DevelopmentChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleVitamin DVitamin D Deficiency25-hydroxyvitamin DBiomarkersVitamin D

Identifiers

PMID23881647
OpenAlexW2069232735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.